Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processing.
about
The use of small molecule high-throughput screening to identify inhibitors of the proteinase 3-NB1 interaction.Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Impaired phagocytosis and reactive oxygen species production in phagocytes is associated with systemic vasculitis.Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.An approach to the diagnosis and management of systemic vasculitis.How anti-neutrophil cytoplasmic autoantibodies activate neutrophils.Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis).Neutral serine proteases of neutrophils.Characterization of the CD177 interaction with the ANCA antigen proteinase 3.Surface receptor CD177/NB1 does not confer a recruitment advantage to neutrophilic granulocytes during human peritonitis.Complement receptor Mac-1 is an adaptor for NB1 (CD177)-mediated PR3-ANCA neutrophil activation.Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils.Loss of expression of neutrophil proteinase-3: a factor contributing to thrombotic risk in paroxysmal nocturnal hemoglobinuria.Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP.Gene silencing and a novel monoallelic expression pattern in distinct CD177 neutrophil subsets.Proteinase 3 expression on the neutrophils of patients with paroxysmal nocturnal hemoglobinuria.Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis.
P2860
Q33574031-8B0A5C34-E9AC-40C9-BA62-7C4A5FA6E3D6Q34149948-E0AFA9D1-F1D1-462B-BC0E-7B9A4DFF725AQ35996558-3D72F864-D128-4721-A395-8A99A8FB2FA8Q37421806-45FA3A45-A2E2-4891-AD00-07E56FF52816Q37673239-72F96B07-DB4F-4AF9-BE3C-7F422D532393Q38031925-0AD760F4-6314-45BA-888D-9B4DF909AA46Q38079492-99ED3E97-243D-482F-A247-953DEFABEDC9Q38936537-F4E4AEDF-4DEB-4153-BD3B-71EB2F8CCD7FQ42152311-7650B8CE-BDDC-4FC9-BC5D-12350F1C4698Q42152322-A517EBAC-F38E-4749-B634-7224867BA100Q42152357-42CD7EBB-57AC-464E-B4E7-0ECA89512A97Q42550003-978FB3B8-77AE-4E84-8C17-B0F4DA2B4C4AQ42783308-BF53FC47-313C-4504-8F53-BB9995EDB329Q43278864-12D1F4F2-FAFA-4632-9622-550FBFB543C8Q47106268-F0F9F62F-04B2-47CC-B0D5-FFB64CFE8FA8Q50171786-3865BB01-29C4-43D0-9B4D-C87BB4C81084Q55229139-AA6C1F7F-983C-4FC6-A9A0-43B0BBF0C971
P2860
Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processing.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neutrophil surface presentatio ...... ends on N-terminal processing.
@ast
Neutrophil surface presentatio ...... ends on N-terminal processing.
@en
Neutrophil surface presentatio ...... ends on N-terminal processing.
@nl
type
label
Neutrophil surface presentatio ...... ends on N-terminal processing.
@ast
Neutrophil surface presentatio ...... ends on N-terminal processing.
@en
Neutrophil surface presentatio ...... ends on N-terminal processing.
@nl
prefLabel
Neutrophil surface presentatio ...... ends on N-terminal processing.
@ast
Neutrophil surface presentatio ...... ends on N-terminal processing.
@en
Neutrophil surface presentatio ...... ends on N-terminal processing.
@nl
P2093
P2860
P921
P1476
Neutrophil surface presentatio ...... ends on N-terminal processing.
@en
P2093
C Eulenberg
R Kettritz
S von Vietinghoff
P2860
P304
P356
10.1111/J.1365-2249.2008.03663.X
P577
2008-06-01T00:00:00Z